PODXL
Basic information
Region (hg38): 7:131500262-131558217
Links
Phenotypes
GenCC
Source:
- young-onset Parkinson disease (Supportive), mode of inheritance: AR
- atypical juvenile parkinsonism (Supportive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PODXL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 15 | 62 | |||
missense | 67 | 17 | 93 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 4 | 2 | 8 | ||
non coding | 10 | 20 | 30 | |||
Total | 3 | 1 | 75 | 74 | 48 |
Variants in PODXL
This is a list of pathogenic ClinVar variants found in the PODXL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-131504303-A-C | PODXL-related disorder | Likely benign (Dec 13, 2022) | ||
7-131504305-A-C | PODXL-related disorder | Likely benign (Dec 13, 2022) | ||
7-131504335-A-G | Benign (Mar 20, 2022) | |||
7-131504336-T-C | Inborn genetic diseases | Uncertain significance (Jul 25, 2023) | ||
7-131504346-C-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Aug 16, 2021) | ||
7-131504348-T-C | Likely benign (May 01, 2023) | |||
7-131504351-G-A | Inborn genetic diseases | Uncertain significance (Apr 08, 2022) | ||
7-131504353-C-T | Likely benign (Oct 27, 2021) | |||
7-131504370-C-T | PODXL-related disorder | Likely benign (Dec 11, 2023) | ||
7-131504377-G-A | Likely benign (Jan 20, 2023) | |||
7-131504381-T-C | Likely benign (Apr 23, 2021) | |||
7-131504382-C-T | Uncertain significance (Feb 24, 2022) | |||
7-131504383-C-A | Benign (Jan 28, 2024) | |||
7-131504411-T-A | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
7-131504412-T-C | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
7-131504415-TCTC-T | Likely benign (Aug 06, 2022) | |||
7-131504424-T-C | Inborn genetic diseases | Uncertain significance (Feb 10, 2022) | ||
7-131504428-A-C | Likely benign (Mar 28, 2018) | |||
7-131504431-A-G | Likely benign (Jun 14, 2021) | |||
7-131504449-C-T | PODXL-related disorder | Benign/Likely benign (Jan 18, 2024) | ||
7-131504451-G-T | Uncertain significance (Oct 17, 2022) | |||
7-131504464-A-G | Likely benign (Aug 20, 2023) | |||
7-131504482-T-C | Benign (Mar 27, 2023) | |||
7-131504504-C-T | Inborn genetic diseases | Uncertain significance (Jul 14, 2023) | ||
7-131504505-G-A | Uncertain significance (Oct 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PODXL | protein_coding | protein_coding | ENST00000378555 | 9 | 57956 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00103 | 0.997 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.672 | 271 | 304 | 0.891 | 0.0000169 | 3541 |
Missense in Polyphen | 65 | 82.487 | 0.78801 | 1003 | ||
Synonymous | 0.121 | 135 | 137 | 0.987 | 0.00000892 | 1196 |
Loss of Function | 2.69 | 9 | 22.9 | 0.394 | 0.00000135 | 247 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000443 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the regulation of both adhesion and cell morphology and cancer progression. Function as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell- cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR- dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells. {ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Primary Focal Segmental Glomerulosclerosis FSGS;Ectoderm Differentiation;Hepatitis C and Hepatocellular Carcinoma
(Consensus)
Recessive Scores
- pRec
- 0.0901
Intolerance Scores
- loftool
- 0.580
- rvis_EVS
- 1.38
- rvis_percentile_EVS
- 94.6
Haploinsufficiency Scores
- pHI
- 0.263
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.414
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.450
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Podxl
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype;
Zebrafish Information Network
- Gene name
- podxl
- Affected structure
- pronephric glomerular capsule
- Phenotype tag
- abnormal
- Phenotype quality
- cystic
Gene ontology
- Biological process
- cell adhesion;negative regulation of cell adhesion;cell migration;negative regulation of cell-cell adhesion;positive regulation of cell migration;regulation of microvillus assembly;positive regulation of cell-cell adhesion mediated by integrin;glomerular visceral epithelial cell development;epithelial tube formation
- Cellular component
- ruffle;extracellular space;nucleolus;cytoplasm;microtubule organizing center;plasma membrane;integral component of plasma membrane;apical plasma membrane;lamellipodium;filopodium;microvillus membrane;slit diaphragm;intracellular membrane-bounded organelle;membrane raft;extracellular exosome
- Molecular function
- protein binding